These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 11139569

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects.
    Thirunavukkarasu K, Miles RR, Halladay DL, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE.
    J Biol Chem; 2001 Sep 28; 276(39):36241-50. PubMed ID: 11451955
    [Abstract] [Full Text] [Related]

  • 4. Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling.
    Shi X, Yang X, Chen D, Chang Z, Cao X.
    J Biol Chem; 1999 May 07; 274(19):13711-7. PubMed ID: 10224145
    [Abstract] [Full Text] [Related]

  • 5. The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer.
    Brown CO, Chi X, Garcia-Gras E, Shirai M, Feng XH, Schwartz RJ.
    J Biol Chem; 2004 Mar 12; 279(11):10659-69. PubMed ID: 14662776
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.
    Ishida W, Hamamoto T, Kusanagi K, Yagi K, Kawabata M, Takehara K, Sampath TK, Kato M, Miyazono K.
    J Biol Chem; 2000 Mar 03; 275(9):6075-9. PubMed ID: 10692396
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H, Kaji H, Hendy GN, Canaff L, Komori T, Sugimoto T, Chihara K.
    J Biol Chem; 2004 Sep 24; 279(39):40267-75. PubMed ID: 15150273
    [Abstract] [Full Text] [Related]

  • 10. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
    Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, Ten Dijke P, Heldin CH, Ericsson J, Moustakas A.
    Mol Cell Biol; 2003 Jul 24; 23(13):4494-510. PubMed ID: 12808092
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction.
    Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M, Miyazono K.
    J Cell Sci; 2001 Apr 24; 114(Pt 8):1483-9. PubMed ID: 11282024
    [Abstract] [Full Text] [Related]

  • 12. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK.
    Mol Endocrinol; 2001 Jun 24; 15(6):946-59. PubMed ID: 11376113
    [Abstract] [Full Text] [Related]

  • 13. A novel nuclear export signal in Smad1 is essential for its signaling activity.
    Xiao Z, Brownawell AM, Macara IG, Lodish HF.
    J Biol Chem; 2003 Sep 05; 278(36):34245-52. PubMed ID: 12821673
    [Abstract] [Full Text] [Related]

  • 14. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.
    Kawai S, Faucheu C, Gallea S, Spinella-Jaegle S, Atfi A, Baron R, Roman SR.
    Biochem Biophys Res Commun; 2000 May 19; 271(3):682-7. PubMed ID: 10814522
    [Abstract] [Full Text] [Related]

  • 15. Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes.
    Park GT, Morasso MI.
    Nucleic Acids Res; 2002 Jan 15; 30(2):515-22. PubMed ID: 11788714
    [Abstract] [Full Text] [Related]

  • 16. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis.
    Katagiri T, Imada M, Yanai T, Suda T, Takahashi N, Kamijo R.
    Genes Cells; 2002 Sep 15; 7(9):949-60. PubMed ID: 12296825
    [Abstract] [Full Text] [Related]

  • 17. A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs).
    Lin Y, Martin J, Gruendler C, Farley J, Meng X, Li BY, Lechleider R, Huff C, Kim RH, Grasser WA, Paralkar V, Wang T.
    BMC Cell Biol; 2002 Jun 21; 3():15. PubMed ID: 12097147
    [Abstract] [Full Text] [Related]

  • 18. [Co-expression of human bone morphogenetic protein-2 and osteoprotegerin in myoblast C2C12].
    Liu JZ, Hu YY, Ji ZL.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Jan 21; 17(1):1-4. PubMed ID: 12916296
    [Abstract] [Full Text] [Related]

  • 19. Molecules mimicking Smad1 interacting with Hox stimulate bone formation.
    Liu Z, Shi W, Ji X, Sun C, Jee WS, Wu Y, Mao Z, Nagy TR, Li Q, Cao X.
    J Biol Chem; 2004 Mar 19; 279(12):11313-9. PubMed ID: 14672939
    [Abstract] [Full Text] [Related]

  • 20. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
    Kim K, Kim JH, Lee J, Jin HM, Lee SH, Fisher DE, Kook H, Kim KK, Choi Y, Kim N.
    J Biol Chem; 2005 Oct 21; 280(42):35209-16. PubMed ID: 16109714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.